NAD+ biomarker_for blood alcohol level
Evidence from:
primary |
all sources
Evidence (1 sources)
Identification of novel bone-specific molecular targets of binge alcohol and ibandronate by transcriptome analysis.
(2008)
PMID:18537941
cited
Blood alcohol levels were determined by NAD+ reduction assay
confidence: 0.95